University Lab Partners’ Post

Digital panel discussion about transfer from academic research into business in the life sciences. 🧬🧫🧑🔬 Join and gain expert insights!💡

They’re saving lives—and the planet. The forward-thinking innovators behind Vektor Medical, Inc., an AI-based cardiac localization and analysis technology, and Fjord Phyto, a unique participatory science platform that intertwines climate science and tourism, took home the top prizes during the inaugural Chancellor’s Innovation Awards celebration. 🏆 The Chancellor’s Innovation Awards, which opened for nominations last September, were created to recognize standouts in two distinguished categories, each with a cash prize: Faculty Startup of the Year and Student/Alumni Innovator of the Year. This year’s winners represent just two of the more than 1,000 startups that have launched out of UC San Diego since the university’s founding in 1960. In the last three fiscal years alone, 49 startups have been licensed from university technologies, and more than $51 million in funding has been acquired by UC San Diego startups through venture capital investment, private equity, mergers and acquisitions over the last three calendar years. #AI #ClimateScience #Startup #UCSanDiego

I was invited to speak today as #keynote panelist at Future Labs Live Basel and share my thoughts as #investor on ‚„How do we create a synergised lab community at the forefront of science, innovation and digital technology?“ my fellow panelists included Vincent R. (moderator, CSEM )(euRobotics aisbl) Zisis Kozlakidis (World Health Organization) Dr. Bernd Liepert and Thomas Bauernhansl (Technologiemanagement am Fraunhofer IPT). What did I share with panel and audience: 1) collaboration and multidisciplinary approach is key to realize innovative idea 2) academia to provide holistic training to scientists to become entrepreneurs, taking the risk founding a start up 3) public-private partnership and funding is key to finance basic research and support spin-off from university to generate first data to enable financing round with private investors 4) European investors are rather risk averse which on one hand leads to good investment and higher return of investment than other territories investors but this means huge challenge for European start ups to access financing 5) need for collaboration between industry and regulators to develop pragmatic legislation while ensuring patients safety at highest priority to also support innovation and not unrealistic burden for start ups 6) increase cooperation between big corporates and start ups to accelerate innovation and time to market 7) encourage people, especially those with Know-how in the field to consider also direct investment where they can also support start ups with Know-how 8) and finally what is in my heart to increase significantly the number of women in venture capital firms as well as private investors to change current situation where female founders hardly get financing from investors We need diversity in all aspects to solve the today and tomorrow problems Thanks very much to Ellie Whitehead for organizing this very interesting event and Vincent R. for excellent moderation and my fellow panelists for stimulating discussions #start-ups #innovation #collaboration #meaningful investment #multi-disciplinary #female founders #public-private partnership #Innosuisse #sustanability

🚀 Exciting News! We're thrilled to launch Nordic Science Investments, a VC fund aiming to propel research-based deep tech across the Nordics. Our mission: transform unseen scientific discoveries into future breakthroughs through partnerships with founders and universities.   🎉 First Closing Achieved! Our team, composed of experienced professionals from the academic and investment world, has successfully completed the first closing of our first €60M fund. This milestone marks the beginning of our journey to back university spinouts, with our first investments already underway.   🌐 Bridging the Gap With our tech transfer expertise, we're set to fast-track spinout creation in the Nordics, collaborating already with several Finnish universities. We address commercialisation gaps in the spinout formation process, aiming to boost spinout generation in local ecosystems.   💡 A Vote of Confidence Heartfelt thanks to our investors, entrepreneurs, and advisors for their trust and support. Your encouragement is essential for driving our impact.   NSI founding team Alexandra Gylfe PhD MBA, Anssi Uimonen, Matti Hautsalo and Jari Strandman   #venturecapital #deeptech #innovation #techtransfer #spinout #science

We are feeling incredibly inspired and energized after visiting the Broad Institute of MIT and Harvard! Boston really is a hotbed for groundbreaking innovation, and we are fortunate enough to work with some of the leading biotech companies driving positive change in the world. Witnessing the groundbreaking research unfolding at the Broad Institute was a humbling experience. Their relentless pursuit to decode disease and translate it into life-saving therapies is nothing short of awe-inspiring. This, coupled with the collaborative spirit among Boston's vibrant biotech community, creates an electrifying ecosystem to be a part of. It's a constant reminder of the incredible potential technology holds to impact lives and redefine what's possible. This experience reminds us of the incredible impact technology can have on the world. It's not just about building software or managing networks; it's about empowering people to do amazing things. And in the case of biotech, it's about improving lives and pushing the boundaries of what's possible. Feeling grateful to be a part of this vibrant community and excited to see what the future holds! #biotech #innovation #boston #broadinstitute #mit #harvard #grateful #makinganimpact

We have the blueprints of success – but we must go further. Unlocking regional capital and devolving decision-making on innovation spending will be the next stage in developing the wider UK innovation economy and likely a key focus for the next Government....

SEMINAR COMING UP. "Exploring Startup Support and Trends in Life Sciences". 💡📅⌚ House Breakfast & Seminar, Tvistevägen 48, February 22, 8:30 AM - 9:30 AM. ✨Join us for a breakfast and a seminar featuring speakers Lotta Edvinsson (senior consultant and temporary team manager) and Kim Isaksson (senior consultant) from Knightec. They will discuss how Knightec assists startup companies and share insights into current trends in the Life Science industry. More info and registration 👇👇👇 #umeåmerlifescience

One of our key missions at Creation-Space is to transform Mitzpe Ramon into a leading innovation hub for companies pushing the boundaries in extreme environments—both on Earth and in space. We’ve secured the right partnerships, funding, and bureaucratic support to make this a reality. Now, we just need to ensure it's done right! We’ve created a survey for technology companies to tell us what their ideal environment for innovation looks like. Please help us by sharing this survey. https://wkf.ms/4easXTN Let's make Mitzpe Ramon the ultimate destination for innovation! Jewish National Fund - USA Merage Foundation Israel מנהלת הצמיחה | The National Program for Economic Growth

SOWING THE SEEDS OF THE FUTURE 🌱 ... and what has that to do with a visitor's badge? It's Monday, and our own Mikael is back after a week-long, intensive summer school at BII. The aim of the summer school was to build the future startups within biotech and biosolutions. And that it did! Despite Denmark enjoying some of the most innovative research environments, leading to countless of spinouts, our founders still experience barriers to success. Barriers we ought to tear down, if we are to reap the benefits of those future seeds, including: 👣 "There is no try, only do": Founders are not only embarking to change global markets, but must also to change themselves, becoming leaders and not just scientists. We need to give them the leadership tools to succeed. 💡 "Publish and perish": Founders must unlearn everything they've been taught at university, as if they publish their groundbreaking idea before having a patent, the whole business can be killed then and there. Therefore, patents and IP rights are crucial. 🚧 "Regulation can kill your idea": Regulation is designed to manage yesterday's risks, not to incentivize the benefits of future ideas. That's great to avoid re-making earlier mistakes, but we miss innovation to deliver on planetary health. Updating European regulation is indeed needed. ⚰ "The Valley of Death is real - meet its twin": The deeptech sector is unfortunate to experience a known Valley of Death, due to the lack of funding between MVP and commercialization. And it now also have a twin, being lacking test and demo facilities to actually test your MVP. We need to secure access to world-class facilities, if we are to keep successful startups in Europe. You get the idea. We have lots of work ahead of us to keep Denmark on the forefront. And that's the mission of DI Bio. Oh, and the visitor's badge? As a way to keep BioInnovation Institute present in your mind, visitors are encouraged to moist the badge and plant it to see your new chamomile plant grow in your home. Neat. That's how you sow the seeds of the future. 🚀

"Remember, AI's value lies in delivering better drugs, not just algorithms." -Its amazing to see Dave Latshaw II, PhD, MBA, getting an opportunity to share one of the key reasons we started BioPhy. 👨🔬 Great panel lead by Zach Taft, MBA, Co-Founder, Clinical Research Innovation Consortium (CRIC), Memorial Sloan Kettering Cancer Center 🔬 Accelerating Drug Development: Harnessing AI as a Problem-Solving Tool "Explore the latest in AI/ML investments transforming drug discovery. Case studies showcase AI's role in drug development. From research to clinical, AI enhances efficiency. Cutting-edge advances like LLMs revolutionize drug discovery. Remember, AI's value lies in delivering better drugs, not just algorithms. Prioritize rigorous clinical validation for investor and patient confidence. Join us to invest in a future where AI serves patients and drives real impact."